Celularity Inc. GXGXW
At closeJul 19, 2021, 12:00 AM EDT
- Market cap
- 237.67M
- Volume
- 2.61M
- Open
- 1.17
- Previous close
- 1.70
- Day's range
- 1.17 – 2.40
- 52-week range
- 1.17 – 2.40
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About Celularity Inc.
Celularity Inc., a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- celularity.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on GXGXW — it syncs with the Stock Master app.